SOLENO THERAPEUTICS INCSLNOEarnings & Financial Report
Nasdaq
SLNO Q3 2025 Key Financial Metrics
Revenue
$66.0M
Gross Profit
$64.9M
Operating Profit
$22.1M
Net Profit
$26.0M
Gross Margin
98.3%
Operating Margin
33.5%
Net Margin
39.4%
YoY Growth
N/A
EPS
$0.47
Financial Flow
SOLENO THERAPEUTICS INC Q3 2025 Financial Summary
SOLENO THERAPEUTICS INC reported revenue of $66.0M for Q3 2025, with a net profit of $26.0M (39.4% margin). Cost of goods sold was $1.1M, operating expenses totaled $42.8M.
Key Financial Metrics
| Total Revenue | $66.0M |
|---|---|
| Net Profit | $26.0M |
| Gross Margin | 98.3% |
| Operating Margin | 33.5% |
| Report Period | Q3 2025 |
Income Statement
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $32.7M | $66.0M |
| YoY Growth | N/A | N/A | N/A | N/A |
Balance Sheet
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Assets | $304.1M | $296.7M | $332.3M | $599.9M |
| Liabilities | $23.4M | $32.0M | $92.2M | $105.1M |
| Equity | $280.8M | $264.7M | $240.1M | $494.8M |
Cash Flow
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Operating CF | $-17.7M | $-14.9M | $-12.6M | $43.5M |